Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25 (original) (raw)

• Iwakura, Y., Ishigame, H., Saijo, S. & Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149–162 (2011).
  CAS PubMed Google Scholar
• Yang, X.O. et al. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063–1075 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kagami, S., Rizzo, H.L., Kurtz, S.E., Miller, L.S. & Blauvelt, A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 185, 5453–5462 (2010).
  CAS PubMed Google Scholar
• Gaffen, S.L. Recent advances in the IL-17 cytokine family. Curr. Opin. Immunol. 23, 613–619 (2011).
  CAS PubMed PubMed Central Google Scholar
• Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
  CAS PubMed PubMed Central Google Scholar
• Dong, C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6, 329–333 (2006).
  CAS PubMed Google Scholar
• Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
  CAS PubMed Google Scholar
• Cua, D.J. & Tato, C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479–489 (2010).
  CAS PubMed Google Scholar
• Chang, S.H. & Dong, C. Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell. Signal. 23, 1069–1075 (2011).
  CAS PubMed Google Scholar
• Hartupee, J., Liu, C., Novotny, M., Li, X. & Hamilton, T. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 179, 4135–4141 (2007).
  CAS PubMed Google Scholar
• Wright, J.F. et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J. Immunol. 181, 2799–2805 (2008).
  CAS PubMed Google Scholar
• Hu, Y. et al. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 184, 4307–4316 (2010).
  CAS PubMed Google Scholar
• Chang, S.H., Park, H. & Dong, C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281, 35603–35607 (2006).
  CAS PubMed Google Scholar
• Qian, Y. et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8, 247–256 (2007).
  CAS PubMed Google Scholar
• Liu, C. et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci. Signal. 2, ra63 (2009).
  PubMed PubMed Central Google Scholar
• Bulek, K. et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat. Immunol. 12, 844–852 (2011).
  CAS PubMed PubMed Central Google Scholar
• Reyes-Turcu, F.E., Ventii, K.H. & Wilkinson, K.D. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363–397 (2009).
  CAS PubMed Google Scholar
• Lin, S.C. et al. Molecular basis for the unique deubiquitinating activity of the NF-κB inhibitor A20. J. Mol. Biol. 376, 526–540 (2008).
  CAS PubMed Google Scholar
• Li, S. et al. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J. Biol. Chem. 285, 4291–4297 (2010).
  CAS PubMed Google Scholar
• Valero, R. et al. USP25, a novel gene encoding a deubiquitinating enzyme, is located in the gene-poor region 21q11.2. Genomics 62, 395–405 (1999).
  CAS PubMed Google Scholar
• Chang, S.H. & Dong, C. IL-17F: regulation, signaling and function in inflammation. Cytokine 46, 7–11 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2. Immunity 36, 23–31 (2012).
  PubMed PubMed Central Google Scholar
• Chang, S.H. et al. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 35, 611–621 (2011).
  CAS PubMed PubMed Central Google Scholar
• Denuc, A., Bosch-Comas, A., Gonzalez-Duarte, R. & Marfany, G. The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS ONE 4, e5571 (2009).
  PubMed PubMed Central Google Scholar
• Sun, D. et al. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat. Immunol. 12, 853–860 (2011).
  CAS PubMed PubMed Central Google Scholar
• May, M.J. IL-17R signaling: new players get in on the Act1. Nat. Immunol. 12, 813–815 (2011).
  CAS PubMed Google Scholar
• Lamothe, B. et al. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation. J. Biol. Chem. 282, 4102–4112 (2007).
  CAS PubMed Google Scholar
• Shi, P. et al. Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1. Sci. Signal. 4, ra73 (2011).
  PubMed Google Scholar
• Skaug, B., Jiang, X. & Chen, Z.J. The role of ubiquitin in NF-κB regulatory pathways. Annu. Rev. Biochem. 78, 769–796 (2009).
  CAS PubMed Google Scholar
• Boone, D.L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052–1060 (2004).
  CAS PubMed Google Scholar
• Ea, C.K., Sun, L., Inoue, J. & Chen, Z.J. TIFA activates IκB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc. Natl. Acad. Sci. USA 101, 15318–15323 (2004).
  CAS PubMed PubMed Central Google Scholar
• Mao, A.P. et al. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-β (IFN-β) and cellular antiviral response. J. Biol. Chem. 285, 9470–9476 (2010).
  CAS PubMed PubMed Central Google Scholar
• Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361 (2000).
  CAS PubMed Google Scholar
• Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351 (2001).
  CAS PubMed Google Scholar
• Kanayama, A. et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535–548 (2004).
  CAS PubMed Google Scholar
• Xia, Z.P. et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114–119 (2009).
  CAS PubMed PubMed Central Google Scholar
• Fan, Y. et al. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor α- and interleukin-1β-induced IKK/NF-κB and JNK/AP-1 activation. J. Biol. Chem. 285, 5347–5360 (2010).
  CAS PubMed Google Scholar
• Xu, M., Skaug, B., Zeng, W. & Chen, Z.J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 36, 302–314 (2009).
  CAS PubMed PubMed Central Google Scholar
• Zeng, W. et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141, 315–330 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gack, M.U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916–920 (2007).
  CAS PubMed Google Scholar
• Zhu, S. et al. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J. Exp. Med. 207, 2647–2662 (2010).
  CAS PubMed PubMed Central Google Scholar
• He, J.Q., Oganesyan, G., Saha, S.K., Zarnegar, B. & Cheng, G. TRAF3 and its biological function. Adv. Exp. Med. Biol. 597, 48–59 (2007).
  PubMed Google Scholar
• Maezawa, Y. et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J. Immunol. 176, 1013–1018 (2006).
  CAS PubMed Google Scholar
• Angkasekwinai, P. et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204, 1509–1517 (2007).
  CAS PubMed PubMed Central Google Scholar
• Bot, J. et al. Culturing mouse peritoneal mesothelial cells. Pathol. Res. Pract. 199, 341–344 (2003).
  PubMed Google Scholar
• Wang, J. et al. Pneumocystis carinii activates the NF-κB signaling pathway in alveolar epithelial cells. Infect. Immun. 73, 2766–2777 (2005).
  CAS PubMed PubMed Central Google Scholar
• Bosch-Comas, A., Lindsten, K., Gonzalez-Duarte, R., Masucci, M.G. & Marfany, G. The ubiquitin-specific protease USP25 interacts with three sarcomeric proteins. Cell. Mol. Life Sci. 63, 723–734 (2006).
  CAS PubMed Google Scholar
• Zhong, B. et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30, 397–407 (2009).
  CAS PubMed Google Scholar
• Zhong, B. et al. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. J. Immunol. 184, 6249–6255 (2010).
  CAS PubMed Google Scholar
• Li, Q. et al. Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination. Proc. Natl. Acad. Sci. USA 108, 19341–19346 (2011).
  CAS PubMed PubMed Central Google Scholar